The trajectory of clinical responses in patients with early rheumatoid arthritis who achieve sustained remission in response to abatacept: subanalysis of AVERT-2, a randomized phase IIIb study

BACKGROUND: AVERT-2 (a phase IIIb, two-stage study) evaluated abatacept + methotrexate versus methotrexate alone, in methotrexate-naive, anti-citrullinated protein antibody-positive patients with early (≤ 6 months), active RA. This subanalysis investigated whether individual patients who achieved th...

Descripción completa

Detalles Bibliográficos
Autores principales: Emery, Paul, Tanaka, Yoshiya, Bykerk, Vivian P., Bingham, Clifton O., Huizinga, Thomas W. J., Citera, Gustavo, Huang, Kuan-Hsiang Gary, Wu, Chun, Connolly, Sean E., Elbez, Yedid, Wong, Robert, Lozenski, Karissa, Fleischmann, Roy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10122306/
https://www.ncbi.nlm.nih.gov/pubmed/37087459
http://dx.doi.org/10.1186/s13075-023-03038-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10122306/
https://www.ncbi.nlm.nih.gov/pubmed/37087459
http://dx.doi.org/10.1186/s13075-023-03038-2

Ejemplares similares